These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4125742)

  • 1. Chemotherapeutic drugs marked with radioactive isotopes.
    Monod O; Rymer M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):245-9. PubMed ID: 4125742
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytostatic therapy of tumors of the lung].
    De Marco F; Saviano G; Tenore G
    Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin anticoagulation as adjuvant to chemotherapy in carcinoma of the lung.
    Elias EG
    J Med; 1974; 5(1):114-32. PubMed ID: 4364885
    [No Abstract]   [Full Text] [Related]  

  • 4. Scintigraphic investigation of the uptake of radioactive mercury in lung tumours.
    Pokorná I; Klvana M; Klimo J
    Neoplasma; 1971; 18(3):317-23. PubMed ID: 5093951
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
    Schaerer R; Sotto JJ; Wiget U; Perdrix A; Bensa JC; Ribaud P
    Eur J Cancer (1965); 1977; 13(4-5):425-8. PubMed ID: 68881
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
    Takita H; Brugarolas A; Mittelman A; Vincent R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
    [No Abstract]   [Full Text] [Related]  

  • 8. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study comparing irradiation alone to irradiation plus procarbazine in inoperable bronchogenic carcinoma.
    Landgren RC; Hussey DH; Samuels ML; Leary WV
    Radiology; 1973 Aug; 108(2):403-6. PubMed ID: 4578183
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
    Host H
    Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
    [No Abstract]   [Full Text] [Related]  

  • 11. Bronchial arterial perfusion with cytotoxic agents for bronchogenic carcinoma. Preliminary report.
    Tate CF; Viamonte M; Agnew JR
    Am Rev Respir Dis; 1968 Apr; 97(4):685-93. PubMed ID: 4296229
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
    Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vincristine (NSC 67574) in non-small cell bronchogenic carcinoma. Results of a phase II clinical study.
    Brugarolas A; Lacave AJ; Ribas A; Miralles MT
    Eur J Cancer (1965); 1978 May; 14(5):501-5. PubMed ID: 348479
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease.
    Mountain CF
    Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
    Bonadonna G; Tancini G; Bajetta E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of pulmonary scintigraphy with mercurial compounds.
    Gotta H; Chwojnik A; Martínez Seeber J; Pecorini V
    Nucl Med (Stuttg); 1974 Jan; 12(4):275-85. PubMed ID: 4824051
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
    Perevodchikova NI; Bychkov MB
    Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
    Curtis JE
    Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophosphamide plus emetine in lung cancer.
    Street EW
    Lancet; 1972 Aug; 2(7773):381-2. PubMed ID: 4114753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.